Certara, Inc. announced the departure of Leif E. Pedersen from his role as President and Chief Commercial Officer, effective August 1, 2026. The company intends to retain Mr. Pedersen in a Senior Advisor capacity to assist with transition matters until December 31, 2026, at which point his employment will be terminated without cause. Upon termination, he is entitled to severance benefits under his existing employment agreement and the Company’s Executive Officer Severance Policy. Certara operates in the pharmaceutical industry, providing regulatory consulting and modeling services.

John E. Gallagher III resigned as Senior Vice President and Chief Financial Officer on June 11, 2026, to pursue another opportunity, with an effective departure date of July 14, 2026. The company appointed Faiz Mohammed, current Senior Vice President of Finance and Treasurer, as Interim CFO, principal financial officer, and principal accounting officer effective July 15, 2026. The company reaffirmed its full-year 2026 guidance in a press release dated June 17, 2026. Certara, Inc. provides biosimulation software and services for the pharmaceutical and biotechnology industries.